justbacked

Biopharma, Biotechnology, Health Care

ClearNote Health

ClearNote Health raised $52M in a Series D announced on May 27, 2026, led by Mattias Westman, Pathology Asia Holdings, Stephen Quake, Sandy Weill. Since then it has posted 5 roles (4 still open), the first 146 days after it. With 5 open roles it is hiring more than 3% of the 67 Series D+ startups on JustBacked (median: 49). In total it has raised $122M over 2 rounds from 4 investors.

Roles posted per month since the round
  • October 20263
  • November 20262

From ClearNote Health's own hiring system, by posting date. Tracked since Oct 4, 2026; roles that closed before then aren't counted.

ClearNote Health delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.

Why join ClearNote Health?

This could be huge if ClearNote Health, a San Diego diagnostics company, can turn a simple DNA blood test into an early warning for cancers that have few detection options today. Its epigenomic platform already targets pancreatic and ovarian cancer, and a $52M Series D with Pathology Asia Holdings and Sandy Weill among the backers lifts total funding to $122M.

JustBacked's take, based on ClearNote Health's own site and its funding and hiring data.

Series D · $52M · 178d agoclearnotehealth.com

Hiring velocity

Open roles
5
Added, 30 days
+4
Added, 7 days
+0
Closed, 30 days
3
Raised
178 days ago
Led by
Mattias Westman, Pathology Asia Holdings, Stephen Quake, Sandy Weill
Team size
11-50
HQ
San Diego, California, United States
Newest role
7d ago
Tracked since
Oct 4, 2026

Where they're hiring

People1
Clinical1
Customer1
Marketing1
Engineering1

Open roles at ClearNote Health

Source: clearnotehealth.com, checked daily.